Letteratura scientifica selezionata sul tema "Mucopolysaccharidosis Metabolism Disorders"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Mucopolysaccharidosis Metabolism Disorders".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Mucopolysaccharidosis Metabolism Disorders"
Vasilev, Filipp, Aitalina Sukhomyasova e Takanobu Otomo. "Mucopolysaccharidosis-Plus Syndrome". International Journal of Molecular Sciences 21, n. 2 (9 gennaio 2020): 421. http://dx.doi.org/10.3390/ijms21020421.
Testo completoScarpa, Maurizio, Charles Marques Lourenço e Hernán Amartino. "Epilepsy in mucopolysaccharidosis disorders". Molecular Genetics and Metabolism 122 (dicembre 2017): 55–61. http://dx.doi.org/10.1016/j.ymgme.2017.10.006.
Testo completoKaczor-Kamińska, Marta, Kamil Kamiński e Maria Wróbel. "Heparan Sulfate, Mucopolysaccharidosis IIIB and Sulfur Metabolism Disorders". Antioxidants 11, n. 4 (30 marzo 2022): 678. http://dx.doi.org/10.3390/antiox11040678.
Testo completoBaxi, Kalgi, Ashish Jagati e Pooja Agarwal. "Mucopolysachharidosis-II: A Rare Case Report". Nepal Journal of Dermatology, Venereology & Leprology 18, n. 1 (8 ottobre 2020): 80–82. http://dx.doi.org/10.3126/njdvl.v18i1.25996.
Testo completoAlden, Tord D., Hernán Amartino, Amauri Dalla Corte, Christina Lampe, Paul R. Harmatz e Leonardo Vedolin. "Surgical management of neurological manifestations of mucopolysaccharidosis disorders". Molecular Genetics and Metabolism 122 (dicembre 2017): 41–48. http://dx.doi.org/10.1016/j.ymgme.2017.09.011.
Testo completoZapolnik, Paweł, e Antoni Pyrkosz. "Nanoemulsions as Gene Delivery in Mucopolysaccharidosis Type I—A Mini-Review". International Journal of Molecular Sciences 23, n. 9 (26 aprile 2022): 4785. http://dx.doi.org/10.3390/ijms23094785.
Testo completoZapolnik, Paweł, e Antoni Pyrkosz. "Nanoemulsions as Gene Delivery in Mucopolysaccharidosis Type I—A Mini-Review". International Journal of Molecular Sciences 23, n. 9 (26 aprile 2022): 4785. http://dx.doi.org/10.3390/ijms23094785.
Testo completoZahoor, Muhammad Yasir, Huma Arshad Cheema, Sadaqat Ijaz, Muhammad Nadeem Anjum, Khushnooda Ramzan e Munir Ahmad Bhinder. "Mapping of IDUA gene variants in Pakistani patients with mucopolysaccharidosis type 1". Journal of Pediatric Endocrinology and Metabolism 32, n. 11 (26 novembre 2019): 1221–27. http://dx.doi.org/10.1515/jpem-2019-0188.
Testo completoDe Filippis, Concetta, Barbara Napoli, Laura Rigon, Giulia Guarato, Reinhard Bauer, Rosella Tomanin e Genny Orso. "Drosophila D-idua Reduction Mimics Mucopolysaccharidosis Type I Disease-Related Phenotypes". Cells 11, n. 1 (31 dicembre 2021): 129. http://dx.doi.org/10.3390/cells11010129.
Testo completoMarsden, Deborah, e Harvey Levy. "Newborn Screening of Lysosomal Storage Disorders". Clinical Chemistry 56, n. 7 (1 luglio 2010): 1071–79. http://dx.doi.org/10.1373/clinchem.2009.141622.
Testo completoTesi sul tema "Mucopolysaccharidosis Metabolism Disorders"
Litjens, Tom. "The molecular genetics of mucopolysaccharidosis type VI /". Title page, contents and abstract only, 1994. http://web4.library.adelaide.edu.au/theses/09PH/09phl776.pdf.
Testo completoZarrinkalam, Krystyna. "Characterisation of osteoblast function in a feline model of mucopolysaccharidosis type VI". Title page, contents and introduction only, 2001. http://web4.library.adelaide.edu.au/theses/09PH/09phz38.pdf.
Testo completoZarrinkalam, Krystyna Helena. "Characterisation of osteoblast function in a feline model of mucopolysaccharidosis type VI / by Krystyna Zarrinkalam". Thesis, 2001. http://hdl.handle.net/2440/21750.
Testo completoIncludes bibliographical references (leaves 178-231).
xiv, 234, [19] leaves, [56] leaves of plates : ill. (chiefly col.) ; 30 cm.
To further the understanding of the molecular mechanisms that contribute to the skeletal pathology of mucopolysaccharidosis type VI and to investigate the production of organic matrix by mucopolysaccharidosis VI osteoblasts
Thesis (Ph.D.)--University of Adelaide, Dept. of Paediatrics, 2001
Feldhammer, Matthew. "N-acétyltransférase lysosomale : organisation, fonctionnement et défauts moléculaires chez les patients atteints du syndrome de Sanfilippo type C". Thèse, 2009. http://hdl.handle.net/1866/3729.
Testo completoThe acetylation of terminal glucosamine residues by lysosomal N-acetyltransferase (HGSNAT) is an essential part of the catabolic breakdown of heparan sulfate. Defects in this reaction result in the rare autosomal recessive lysosomal storage disorder Sanfilippo syndrome type C (SFC). To date 54 mutations in SFC patients have been reported including 13 splice-site mutations, 11 insertions and deletions, 8 nonsense, 18 missense and 4 polymorphisms, with different phenotypic manifestations. We have identified 10 of them and conducted a comprehensive review discussing the spectrum of Sanfilippo C mutations, their distribution within the patient population as well as how the mutations could potentially affect the structure of HGSNAT. Splicing errors, nonsense mutations, insertions and deletions were all predicted to result in non-functional RNA which is rapidly degraded by cellular quality control mechanisms. The 4 identified polymorphisms resulted in amino acid changes which did not affect the enzyme activity, glycosylation or targeting and were therefore not clinically significant. Polymorphisms, in the context of enzymes are amino acid changes not affecting function, but in the context of nucleic acids can still be considered as missense mutations. Eighteen missense mutations were expressed and shown be inactive due to errors in protein folding providing an explanation for the severe disease progression seen in individuals with these mutations. Misfolded mutants were abnormally glycosylated and retained in the endoplasmic reticulum. Enzyme enhancement/chaperone therapy is a potential treatment option specifically designed to exploit the residual enzyme activity of misfolded mutants in order to clear stored substrates. We demonstrated that treatment of several fibroblast lines of SFC patients with a specific inhibitor of HGSNAT; glucosamine-hydrochloride partially rescued mutant enzyme activity providing a proof of principle for the future use of chaperone therapeutics in the treatment of SFC.
Libri sul tema "Mucopolysaccharidosis Metabolism Disorders"
Frawley, Geoff. Mucopolysaccharidoses. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199764495.003.0064.
Testo completoTomatsu, Shunji, Roberto Giugliani, Tadao Orii, Maurizio Scarpa e Paul Harmatz. Mucopolysaccharidoses Update: Medicine and Health / Endocrinology / Metabolic Disorders. Nova Science Publishers, Incorporated, 2018.
Cerca il testo completoSybert, Virginia P. Metabolic Disease. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780195397666.003.0011.
Testo completoSybert, Virginia P. Metabolic Disease. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190276478.003.0011.
Testo completoCapitoli di libri sul tema "Mucopolysaccharidosis Metabolism Disorders"
Jones, Simon, e Frits A. Wijburg. "Mucopolysaccharidoses, Oligosaccharidoses and Sialic Acid Disorders". In Inborn Metabolic Diseases, 577–90. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-49771-5_39.
Testo completoJones, Simon, e Frits A. Wijburg. "Glycosaminoglycans and Oligosaccharides Disorders: Glycosaminoglycans Synthesis Defects, Mucopolysaccharidoses, Oligosaccharidoses and Sialic Acid Disorders". In Inborn Metabolic Diseases, 765–83. Berlin, Heidelberg: Springer Berlin Heidelberg, 2022. http://dx.doi.org/10.1007/978-3-662-63123-2_41.
Testo completoCervós-Navarro, Jorge, e Henry Urich. "Disorders of Glycosaminoglycan Metabolism (Mucopolysaccharidoses)". In Metabolic and Degenerative Diseases of the Central Nervous System, 110–36. Elsevier, 1995. http://dx.doi.org/10.1016/b978-012165250-0/50004-0.
Testo completoFlorence, Nicholas. "Pediatric Musculoskeletal Radiology". In Ultrasound Guided Procedures and Radiologic Imaging for Pediatric Anesthesiologists, a cura di Anna Clebone, Joshua H. Finkle e Barbara K. Burian, 155–80. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780190081416.003.0014.
Testo completoDeegan, Patrick B., e Timothy M. Cox. "Lysosomal disease". In Oxford Textbook of Medicine, a cura di Timothy M. Cox, 2121–56. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0235.
Testo completo